The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M. Woods, Karrune Woan, Fengdong Cheng, Hongwei Wang, Patricio Perez-Villarroel, Calvin Lee, Maritza Lienlaf, Peter Atadja, Edward Seto, Jeffrey Weber, Eduardo M. Sotomayor, Alejandro Villagra
Dive into the research topics of 'The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity'. Together they form a unique fingerprint.